Financial Performance - The company expects a net loss of between 60 million and 90 million yuan for the fiscal year 2024, compared to a loss of 127.83 million yuan in the previous year, representing a decrease in loss of 29.60%[3] - The net profit attributable to shareholders is projected to be a loss of 14 million to 20 million yuan, which is an increase in loss of 6.47% compared to the previous year's loss of 13.15 million yuan[3] - The basic earnings per share are expected to be a loss of 0.115 to 0.173 yuan per share, compared to a loss of 0.246 yuan per share in the previous year[3] Factors Affecting Performance - The decline in performance is attributed to routine maintenance of production facilities, decreased sales and prices of chemical products, and lower gross profit margins, leading to a decline in operating profit[6] Investment and Income - The company confirmed an investment income of over 94 million yuan from the public transfer of bad debts related to subsidiaries[6] Legal Disputes - The company is involved in ongoing legal disputes that may impact future profits, including a case with Guangfa Bank involving a potential return of 17.99 million yuan and another with Huaxing Bank involving a potential refund of 17.5 million yuan[7][8] Financial Reporting and Caution - The financial data in the earnings forecast has not been audited by a registered accounting firm[4][9] - The specific financial data for the fiscal year 2024 will be detailed in the company's annual report[9] - The company advises investors to be cautious regarding investment risks due to the preliminary nature of the earnings forecast[9] - The company has communicated with its accounting firm regarding the earnings forecast and found no significant discrepancies[5]
ST实华(000637) - 2024 Q4 - 年度业绩预告